in Drug Development
Jeffrey L. Evelhoch, Ph.D., and John R.
Griffiths, M.B.B.S., D.Phil., Organizers Monday, 14
July, 10:30 - 12:30 Last
updated 05 May 2009
Course Description: This two-hour course will provide an introduction to how radiologists can become
involved in the emerging role of MR in drug-development. Examples of applications in
the development of drugs for a variety of diseases will be reviewed.
Educational Objectives: Upon completion of this session, participants should be able to:
the key objectives of an MR study in development of a given drug;
Explain why MR methodology studies (e.g.,
reproducibility, validation) should precede deployment of MR in clinical trials of novel
Recommend MR protocols for use in drug development;
explain how and why these differ from protocols used in routine diagnostic practice;
Recognize the impact of Good Clinical Practice
regulations in the MR study, and advise physicist and physician co-workers accordingly.
Monday, 14 July
David S. Lester and Steve C.R.
The Emerging Role of MR in Drug
John C. Waterton
Imaging and Neurological Drug
Imaging and Cardiovascular Drug
Imaging and Oncologic Drug
Imaging and Arthritis Drug
Charles G. Peterfy
What Radiologists Need to Know
About Roles and Rules in Clinical MR Trials